Challenges in Measuring Low-Value Healthcare
Differences in patient-centric versus service-centric measures make quantifying low-value care difficult.
Review Finds Little Evidence that Electroconvulsive Therapy is Effective for Depression
Researchers examined the dearth of support for Electroconvulsive therapy (ECT) for depressive symptoms in light of studies detailing the associated risks.
Leading Researchers Critique Current Paradigm for Studying ‘Schizophrenia’ Risk
Re-conceptualizing the Clinical-High-Risk/Ultra-High-Risk Paradigm: A critique and reappraisal
Thou Shall Not Criticize Our Drugs
A medical journal is expected to promote an open-minded discussion of treatments, even if findingsâor criticismsâthreaten conventional beliefs. But the American Journal of Psychiatry will not find space for criticism even if it comes from one of the best-known psychiatrists in the world.
More Follow Up Needed for Drugs Granted Accelerated FDA Approval
Drugs to treat serious or life-threatening conditions can receive accelerated FDA approval, but may expose patients to increased safety risks and reduced efficacy.
A Blow to STAT’s Credibility: Ghostwriting/PR Influence
From HealthNewsReview.org: STAT recently published an op-ed praising the role of drug company sales representatives. The physician listed as the author has now revealed that he did...
The Most Promoted Drugs are Those with Little Therapeutic Value, Study Finds
Majority of top-selling and most promoted drugs in Canada are rated as having very limited safety and efficacy.
Silicon Valley Courts Brand-Name Teachers, Raising Ethics Issues
From The New York Times: Tech companies are increasingly recruiting school teachers to help improve and promote their education tools in exchange for perks, including...
Proove Biosciences Sells Off Assets as CEO Departs
From STAT: Proove Biosciences, which sold dubious DNA tests to predict opioid addiction risk, has been placed into court-ordered receivership for restructuring and asset sale. Experts...
Good Psychologist, Bad Psychologist
In this episode on BBC Radio, psychiatrist Raj Persaud reports on the CIA's so-called "enhanced interrogation" program, which has frequently been characterized as torture. He discusses...
Researchers Question Add-On Treatment for ‘Schizophrenia’
A common practice when antipsychotics are found to be ineffective for schizophrenia is to prescribe a second, additional psychoactive medication. Now, a new study suggests that this practice is not supported by the research.
The State of the Evidence Base for Current Medical Products
In this post for Yale Law School's CRITical Thinking, Tom Jefferson discusses some of the factors that currently serve to undermine rational and ethical medical...
Abilify: The Drug That Could Gamble Your Life Away
On this episode of America's Lawyer, Mike Papantonio discusses the numerous lawsuits pending involving the anti-psychotic drug Abilify, which has caused plaintiffs to develop serious...
Biotech Exploits a Loophole in a Federal Transparency Law
From STAT: A small biotech company, AveXis, recently offered a $3,000 honorarium along with paid airfare and lodging to several experts to attend a so-called...
Pharma ‘Getting Away With Murder’ Abroad Thanks to Trump
From STAT: Despite accusing the pharmaceutical industry of "getting away with murder" by charging high drug prices, President Trump is now giving drug companies more power...
Researchers Question the âAdequacy and Legitimacyâ of ADHD Diagnosis
A new article, just published online in the journal Emotional and Behavioural Difficulties, presents research suggesting that the diagnosis of ADHD is philosophically inadequate.
Trust Falls – Are We in a New Phase of Corporate Research?
From The Scholarly Kitchen: We may be in a new phase of corporation-funded research. According to the 2016 Science & Engineering Indicators from the National...
A Supreme Court Pharma Case Deals Consumers a Big Loss
From STAT: The U.S. Supreme Court case of Bristol-Meyers Squibb Co. vs. Superior Court of California, in which hundreds of plaintiffs claimed the drug Plavix...
Vanda Puts Antipsychotic Side Effect Front and Center in TV Ads
From FiercePharma: Vanda Pharmaceuticals, which makes the antipsychotic drug Fanapt, has recently rolled out a national TV campaign to raise awareness of akathisia. The company...
Newly-Revised List of Industry-Independent Experts for Journalists
From HealthNewsReview: For nine years, HealthNewsReview has hosted a one-of-a-kind list of health care industry-independent experts for journalists. The list has now been revised with new...
Ethical Failings in Experimental Drug Safety Trials
Leading human subjects ethics researcher questions exploitation of uninsured minorities in experimental drug trials.
Female Brains are More Active?
From Discover Magazine: Headlines in various news sources reporting on a new study claim that women's brains have been found to be more active than...
ADHD Diagnosis Based on âIllogical Rhetoric,â Analysis Claims
In a philosophically rigorous article, Spanish researcher Marino PĂ©rez-Ălvarez examines the logic of attention-deficit hyperactivity disorder (ADHD).
Dr. Joel Lexchin Says Big Pharma is too Close With Physicians
From The Toronto Star: In his new book Doctors in Denial: Why Big Pharma and the Canadian Medical Profession are too Close for Comfort, Dr. Joel...
Researchers Challenge Popular Beliefs About Adolescent Risk Taking
Adolescent risk taking is explored contextually, beyond models of brain imbalances and adverse consequences.
